Paradigm Biopharmaceuticals Is A Global Biopharmaceutical Company Based In Melbourneaustraliawith Additional Offices In The European Union And The United Stateslisted On The Australian Securities Exchange Under The Code Parthe Company Is Dedicated To Discovering And Developing Pharmaceutical Therapies To Meet Unmet Medical Needsparticularly Through The Repurposing Of Underutilized Molecules The Company Specializes In Late Stage Drug Developmentfocusing On Its Lead Candidatezilosulan Injectable Drug For Treating Osteoarthritisphase 3 Trials For Zilosul Are Currently Underwayand The Company Is Also Exploring The Use Of Pentosan Polysulfate Sodium For Other Conditionsincluding Mucopolysaccharidosis And Various Viral Infectionsparadigm Aims To Improve Patientshealth And Quality Of Life By Providing Effective Treatments Where Options Are Limited
No conferences found for this company.
| Company Name | Paradigm Biopharmaceuticals Pty Ltd |
| Country |
Australia
|
| Address | N/A |
| Telephone | N/A |
| N/A |
